机构风向标 | 兴齐眼药(300573)2025年三季度已披露前十大机构持股比例合计下跌3.08个百分点

Core Insights - XQ Eye Pharmaceutical (300573.SZ) reported its Q3 2025 results, revealing that as of October 28, 2025, nine institutional investors held a total of 10.4442 million shares, representing 4.26% of the company's total share capital. This marks a decrease of 3.08 percentage points in institutional ownership compared to the previous quarter [1] Group 1: Institutional Investors - A total of nine institutional investors disclosed their holdings in XQ Eye Pharmaceutical, with a combined shareholding of 10.4442 million shares, accounting for 4.26% of the total share capital [1] - The institutional ownership decreased by 3.08 percentage points compared to the previous quarter [1] Group 2: Public Funds - One public fund, Invesco Great Wall National Index 2000 Enhanced A, increased its holdings, while two public funds, Nord Quality Consumption and Southern CSI 500 ETF, reduced their holdings [2] - A total of 412 public funds did not disclose their holdings in the current period, including notable funds such as Guofu Deep Value Mixed A and E Fund Value Growth Mixed [2] Group 3: Social Security and Insurance Funds - One social security fund, the National Social Security Fund 502 Portfolio, did not disclose its holdings in the current period [2] - One insurance fund, China Life Insurance Co., Ltd. - Traditional - Ordinary Insurance Product - 005L-CT001, reduced its holdings slightly [2] Group 4: Foreign Investment - One foreign fund, Hong Kong Central Clearing Limited, increased its holdings by 1.48% compared to the previous period [2] - The Kuwait Government Investment Authority did not disclose its holdings in the current period [2]